We are live on
!
Find out more
Victory Capital Management Portfolio holdings
AUM
$178B
1-Year Est. Return
37.23%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$102B
AUM Growth
-$2.08B
(-2%)
Cap. Flow
-$2.66B
Cap. Flow
% of AUM
-2.61%
Top 10 Holdings %
Top 10 Hldgs %
14.91%
Holding
2,573
New
92
Increased
1,013
Reduced
1,261
Closed
104
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SW
Smurfit Westrock
SW
|
+$274M |
| 2 |
American Water Works
AWK
|
+$234M |
| 3 |
Expedia Group
EXPE
|
+$212M |
| 4 |
Performance Food Group
PFGC
|
+$200M |
| 5 |
Maplebear
CART
|
+$194M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$396M |
| 2 |
Zimmer Biomet
ZBH
|
+$332M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$321M |
| 4 |
ManpowerGroup
MAN
|
+$230M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$213M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.63% |
| 2 | Financials | 13.67% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Industrials | 10.96% |
| 5 | Healthcare | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Arcutis Biotherapeutics
ARQT
$3.24B
| $177K | ﹤0.01% |
12,734
-109
| -0.8% | -$1.19K |
|
2227
10x Genomics
TXG
$7.22B
| $177K | ﹤0.01% |
12,338
-299
| -2% | -$4.72K |
|
2228
BioCryst Pharmaceuticals
BCRX
$2.46B
| $176K | ﹤0.01% |
23,381
-1,468
| -6% | -$11.1K |
|
2229
DMC Global
BOOM
$155M
| $175K | ﹤0.01% |
23,871
+1,654
| +7% | +$15.6K |
|
2230
Par Pacific Holdings
PARR
$3.62B
| $175K | ﹤0.01% |
10,691
-61,437
| -85% | -$1.04M |
|
2231
Evolution Petroleum
EPM
$133M
| $175K | ﹤0.01% |
33,451
+20,894
| +166% | +$114K |
|
|
ZUO
2232
DELISTED
Zuora, Inc.
ZUO
| $174K | ﹤0.01% |
17,572
-48,707
| -73% | -$473K |
|
|
AGNT
2233
AGNT Inc
AGNT
$707M
| $174K | ﹤0.01% |
15,103
-275
| -2% | -$3.62K |
|
2234
Getty Images
GETY
$203M
| $171K | ﹤0.01% |
79,384
+20,239
| +34% | +$66.1K |
|
|
BDN
2235
Brandywine Realty Trust
BDN
$530M
| $170K | ﹤0.01% |
30,273
-1,960
| -6% | -$10.9K |
|
|
LGF.A
2236
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $168K | ﹤0.01% |
19,706
-1,479
| -7% | -$11.7K |
|
2237
Sabesp
SBS
$18.4B
| $164K | ﹤0.01% |
+58,934
| New | +$180K |
|
|
MTTR
2238
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $162K | ﹤0.01% |
34,275
-342
| -1% | -$1.62K |
|
2239
Viasat
VSAT
$11.6B
| $158K | ﹤0.01% |
18,553
+471
| +3% | +$4.53K |
|
2240
Perspective Therapeutics
CATX
$342M
| $158K | ﹤0.01% |
49,420
-1,040
| -2% | -$8.49K |
|
2241
Wolfspeed
WOLF
$1.59B
| $157K | ﹤0.01% |
23,640
-1,328
| -5% | -$13.5K |
|
2242
NextDecade
NEXT
$1.83B
| $157K | ﹤0.01% |
20,388
-437
| -2% | -$2.8K |
|
2243
Evolent Health
EVH
$460M
| $156K | ﹤0.01% |
13,833
-215
| -2% | -$3.78K |
|
2244
TFS Financial
TFSL
$4.84B
| $152K | ﹤0.01% |
12,132
+109
| +0.9% | +$1.45K |
|
2245
Novavax
NVAX
$1.3B
| $152K | ﹤0.01% |
18,928
-364
| -2% | -$3.51K |
|
2246
Applied Digital
APLD
$8.42B
| $151K | ﹤0.01% |
19,756
+221
| +1% | +$1.84K |
|
2247
Fastly Inc
FSLY
$4.28B
| $150K | ﹤0.01% |
15,841
-135
| -0.8% | -$1.12K |
|
2248
Definitive Healthcare
DH
$74.2M
| $149K | ﹤0.01% |
36,161
-506,009
| -93% | -$2.21M |
|
2249
SolarEdge
SEDG
$1.97B
| $148K | ﹤0.01% |
10,916
-142
| -1% | -$2.19K |
|
2250
Clover Health Investments
CLOV
$2.45B
| $147K | ﹤0.01% |
46,671
-1,076
| -2% | -$3.85K |
|
Similar funds
VGA
Victory Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Victory Capital Management held 2,573 positions worth $102B, down 2% from $104B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Victory Capital Management's Q4 2024 filing shows 92 new, 1,013 increased, 1,261 reduced and 104 closed positions. Its largest new stake was Ingram Micro Holding: 2,760,805 shares worth $53.5M. The largest sale was Leidos, an estimated $396M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Victory Capital Management's largest Q4 2024 buy was Ingram Micro Holding: 2,760,805 shares worth $53.5M.
- Victory Capital Management added most to Smurfit Westrock in Q4 2024, an estimated $274M increase.
- Victory Capital Management's biggest Q4 2024 reduction was Leidos, cutting an estimated $396M.
- Victory Capital Management fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $73.2M.
- Victory Capital Management's ten largest holdings make up 15% of its $102B portfolio in Q4 2024.
- Victory Capital Management opened 92 new positions and closed 104 in Q4 2024.
- Victory Capital Management's portfolio value fell 2% quarter-over-quarter to $102B.
Based on Victory Capital Management's 13F filing for Q4 2024, filed 6 Feb 2025.